Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Filings indexed 507 across all filing types
Latest filing 2022-12-27 Major Shareholding Noti…
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (the reporter and special related parties), including collateral agreements and changes in voting rights. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-12-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제9회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity'. It details the specific terms of the bond, the acquisition amount, the reason (early redemption request by the bondholder), and the method of disposal (cancellation). This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best categorized as a Capital/Financing Update (CAP).
2022-12-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (including gifts and new special relationships), and contractual obligations (collateral/pledge agreements) of the major shareholder and their special relations. This corresponds to the 'Major Shareholding Notification' category.
2022-12-19 Korean
증권발행결과(자율공시)(제3자배정 유상증자-전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocation capital increase via convertible preferred shares). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance or capital changes.
2022-12-19 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and the closure of the shareholder register for the purpose of determining voting rights for an upcoming Annual General Meeting. It does not contain the full report or presentation materials, but rather serves as a formal regulatory notice. Given the nature of the announcement regarding shareholder meeting logistics, it falls under the general regulatory filing category.
2022-12-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party capital increase (유상증자결정) by Olipass Co., Ltd. It details the issuance of new shares, the purpose of the funds, the third-party allocation details, and the terms of convertible preferred shares. This type of regulatory filing in the Korean market is specifically categorized as a 'Share Issue/Capital Change' (SHA) announcement, as it details the mechanics and terms of a capital increase.
2022-12-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.